Phase 3Completed
Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content
Randomized, Placebo Controlled, Crossover Clinical Study to Analyse the Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content
- Sponsor
- University of Erlangen-Nürnberg Medical School (Academic or other)
- Enrolment
- 59 enrolled
- Conditions
- Diabetes Mellitus Type 2
- Interventions
- Dapagliflozin; Placebo
- Ages
- adults, older adults
- Registry
- NCT02383238
From the registry
Dapagliflozin leads to improved vascular function in the micro- and macrocirculation by action on various cardiovascular risk factors, in particular by effectively controlling hyperglycemia, arterial hypertension and reducing whole sodium content amongst others.
Primary outcomes
- Microcirculation